In a 52-year-old woman with a seated blood pressure of 152/79 mm Hg (stage 1 hypertension), what physical examination components, treatment plan, and baseline laboratory tests are indicated?

Management of Stage 1 Hypertension in a 52-Year-Old Woman

For this 52-year-old woman with stage 1 hypertension (152/79 mmHg), you should first confirm the diagnosis with out-of-office blood pressure measurements (home or ambulatory monitoring), perform a focused physical examination for target organ damage and secondary causes, order baseline laboratory tests including metabolic panel, lipid profile, urinalysis, and ECG, then initiate lifestyle modifications while determining if pharmacotherapy is needed based on her 10-year cardiovascular risk. 1, 2

Confirming the Diagnosis

Before proceeding with treatment, confirm hypertension with out-of-office measurements since her BP is 140-159/90-99 mmHg range:

• Home blood pressure monitoring (HBPM) using the 722 protocol: duplicate readings, twice daily, over 7 consecutive days 1
• Alternatively, use ambulatory blood pressure monitoring (ABPM) if available 1
• If these are not feasible, repeat office measurements on multiple visits 1

This step is critical because office readings may overestimate true BP due to white coat effect.

Physical Examination Components

Target Organ Assessment

Focus your examination on detecting hypertension-mediated organ damage:

Cardiovascular:

• Assess for left ventricular hypertrophy (displaced/sustained apical impulse, S4 gallop)
• Listen for carotid bruits
• Palpate peripheral pulses for evidence of peripheral arterial disease
• Measure BP in both arms (>15 mmHg difference suggests vascular pathology) 2

Orthostatic vital signs:

• Measure BP supine and after 1 minute standing
• Abnormal if SBP drops >20 mmHg or DBP >10 mmHg 2

Body measurements:

• BMI calculation (target 20-25 kg/m²)
• Waist circumference (target <80 cm for women) 1

Signs of secondary hypertension to exclude:

• Thyroid examination (goiter, nodules suggesting thyroid disease)
• Abdominal examination for renal bruits (renovascular disease)
• Skin examination for striae, central obesity, facial plethora (Cushing's syndrome)
• Extremity examination for delayed femoral pulses (coarctation, though rare at this age) 2

Fundoscopic Examination

Not routinely required at this BP level unless BP exceeds 180/110 mmHg or she has diabetes 1

Laboratory Testing

Essential Baseline Tests

Order the following to assess cardiovascular risk, detect target organ damage, and screen for secondary causes 1, 2:

Metabolic panel including:

• Serum creatinine with estimated GFR (eGFR) - assess kidney function
• Serum sodium and potassium - screen for primary aldosteronism if hypokalemia present
• Serum calcium
• Fasting blood glucose - assess diabetes risk

Additional required tests:

• Lipid profile (total cholesterol, LDL, HDL, triglycerides) - for cardiovascular risk assessment 2
• Complete blood count 2
• Urinalysis - screen for proteinuria/hematuria suggesting kidney disease 2
• Thyroid-stimulating hormone (TSH) - exclude thyroid disorders 2
• 12-lead ECG - assess for left ventricular hypertrophy, ischemia, or arrhythmias 1, 2

Optional Tests (Based on Initial Findings)

• Urine albumin-to-creatinine ratio - more sensitive for early kidney damage 1, 2
• Echocardiogram - if ECG shows abnormalities or cardiac symptoms present 1
• Uric acid - may provide additional cardiovascular risk information 2

Treatment Plan

Step 1: Calculate 10-Year Cardiovascular Risk

This is the critical decision point that determines whether to start medication immediately or lifestyle modifications alone 2:

• Use SCORE2 (for ages 40-69) or appropriate risk calculator 1
• If 10-year ASCVD risk <10%: Start with lifestyle modifications alone, reassess in 3-6 months 2
• If 10-year ASCVD risk ≥10%: Start combination of lifestyle modifications AND antihypertensive medication immediately, reassess in 1 month 2

Step 2: Lifestyle Modifications (All Patients)

Dietary interventions:

• Sodium restriction to ~2 g/day (equivalent to ~5 g salt/day, approximately 1 teaspoon) 1
• Adopt Mediterranean or DASH diet patterns 1
• Limit free sugar to <10% of energy intake, avoid sugar-sweetened beverages 1
• Target stable, healthy BMI (20-25 kg/m²) and waist <80 cm 1

Alcohol:

• Limit to <100 g/week of pure alcohol (approximately 7-12 standard drinks depending on size) 1
• Ideally, avoid alcohol completely for best health outcomes 1

Physical activity:

• Moderate-intensity aerobic exercise ≥150 minutes/week (30 minutes, 5-7 days/week) 1
• Add resistance training 2-3 times/week (low to moderate intensity) 1

Tobacco:

• Complete cessation with referral to smoking cessation programs if applicable 1

Step 3: Pharmacotherapy (If Indicated)

If her 10-year ASCVD risk is ≥10%, initiate antihypertensive medication in addition to lifestyle changes 2:

• Start with single-agent therapy for stage 1 hypertension 2
• Choose from first-line agents: ACE inhibitor, ARB, calcium channel blocker, or thiazide diuretic
• Target BP <130/80 mmHg based on home measurements 1

Critical caveat: Do NOT use ACE inhibitor + ARB + renin inhibitor combinations - this is potentially harmful 2

Follow-Up Timeline

If lifestyle modifications only (ASCVD risk <10%):

• Reassess BP and adherence in 3-6 months 2

If starting medication (ASCVD risk ≥10%):

• Reassess BP and tolerance in 1 month 2
• Monitor electrolytes during medication titration 2

If BP remains uncontrolled or secondary hypertension suspected:

• Consider more extensive evaluation for secondary causes 1, 2

Common Pitfalls to Avoid

1. Don't base treatment decisions on single office reading - confirm with out-of-office measurements 1
2. Don't forget cardiovascular risk assessment - this determines whether medication is needed immediately 2
3. Don't order extensive secondary hypertension workup initially unless clinical clues present (hypokalemia, resistant hypertension, suggestive symptoms) 1, 2
4. Don't delay treatment if ASCVD risk is high - stage 1 hypertension with ≥10% risk requires prompt pharmacotherapy 2